Skip to main content
ASND logo

Ascendis Pharma A/S

ASNDNASDAQHealthcareBiotechnology

$225.24Today:- (-)1Y +7.66%

As of Oct 16, 2026 close

Market cap
$15.48B
P/E (TTM)
18.23
Forward P/E
-
Dividend yield
-
52-week range
$186.05$282.15
Volume (live)
-
Avg. volume (3M)
857.03K

Ascendis Pharma A/S (ASND) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Ascendis Pharma A/S had debt-to-equity of -5.35 (up from -8.10), a current ratio of 1.04 (down from 1.17) and return on assets of -6.9% (up from -17.4%). A current ratio of 1.04 means current assets exceed current liabilities.

Ascendis Pharma A/S Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Jan 2023Dec 2021Dec 2020
Valuation Ratios
P/S Ratio-----1059.02
P/B Ratio-----8.78
Price/Tangible Book-----8.84
Enterprise Value Ratios
EV/Revenue-----931.41
Profitability & Returns
Return on Equity (ROE)---818.43%-101.69%-44.54%-58.36%
Return on Assets (ROA)-6.86%-17.38%-29.73%-32.29%-27.35%-24.95%
Return on Capital Employed (ROCE)-58.40%-102.60%-511.40%-150.60%-45.90%-35.70%
Leverage & Solvency Ratios
Debt/Equity-5.35-8.10-4.421.930.120.11
Debt/FCF19.20-----
Liquidity Ratios
Current Ratio1.041.170.951.298.0314.02
Quick Ratio0.720.810.621.067.0313.75
Efficiency Ratios
Asset Turnover0.580.360.280.050.010.01
Inventory Turnover0.320.170.260.12--
Yield & Distribution Ratios
Earnings Yield------5.69%
FCF Yield------3.96%
Buyback Yield-4.69%-2.85%-0.38%-2.37%-8.21%-8.84%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Ascendis Pharma A/S Financial Ratios

What is Ascendis Pharma A/S's debt-to-equity ratio?

Ascendis Pharma A/S's debt-to-equity ratio was -5.35 for fiscal 2025 (period ended Dec 31, 2025). It was -8.10 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition